Role of Uroflowmetry in Patients of Benign Prostatic Hyperplasia Presenting with Lower Urinary Tract Symptoms: Uroflowmetry in Benign Prostatic Hyperplasia

Aijaz Hussain Memon; Mumtaz Ali Chandio; Zahoor Hussain Bhellar; Hameed Ur Rehman; Suhail Akhtar; Asadullah Bhurt

doi:10.54393/pjhs.v5i11.2409

Authors

Aijaz Hussain Memon Department of Urology, People’s University of Medical and Health Sciences for Women, People’s Medical College Hospital, Nawabshah, Pakistan
Mumtaz Ali Chandio Department of Urology, People’s University of Medical and Health Sciences for Women, People’s Medical College Hospital, Nawabshah, Pakistan
Zahoor Hussain Bhellar Department of General Surgery, Khairpur Medical College Hospital, Khairpur, Pakistan
Hameed Ur Rehman Department of Urology, People’s University of Medical and Health Sciences for Women, People’s Medical College Hospital, Nawabshah, Pakistan
Suhail Akhtar Department of Urology, People’s University of Medical and Health Sciences for Women, People’s Medical College Hospital, Nawabshah, Pakistan
Asadullah Bhurt Department of Urology, People’s University of Medical and Health Sciences for Women, People’s Medical College Hospital, Nawabshah, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i11.2409

Keywords:

Benign Prostatic Hyperplasia, Lower Urinary Tract, Uroflowmetry, International Prostate Symptom Score

Abstract

Benign Prostatic Hyperplasia (BPH) is prevalent among aging men, causing Lower Urinary Tract Symptoms (LUTS) that can impact quality of life. Objective: To assess the role of uroflowmetry in determining Lower Urinary Tract Symptom (LUTS) severity in Benign Prostatic Hyperplasia (BPH) patients by examining correlations between symptom scores and uroflowmetric parameters (Qmax, Qavg, PVR, and voiding time). Methods: This cross-sectional study was conducted on sixty BPH male patients presenting with a spectrum of symptom scores based on IPSS. With a standard uroflowmeter, uroflowmetric parameters were determined and correlation coefficients and t-tests between parameters about most severe complaints yielded statistical analyses. Results: Uroflowmetric parameters were significantly different among severity groups of symptoms. Mean Qmax values decreased successively from 12.5 mL/s in mild to severe symptoms of 6.5 mL/s (p < 0.001). The same results were evident for average flow rates, as mean flows at mild were 8.0 mL/s vs severe of 4.0 mL/s (p < 0.001) Residual urine increased from 25 mL to 110 mL (p <0.001 and voiding times from 15 seconds up to 40 seconds (p <0.001). Correlation analysis revealed moderate positive and negative correlations between residual urine and IPSS (r = 0.60), Qmax (r = -0.54), and Qavg (r = -0.50) with IPSS scores (p < 0.001). Conclusion: The importance of uroflowmetry in clinical assessments and management methods was shown by the substantial correlation found between uroflowmetric parameters and the severity of BPH symptoms.

References

Shah A, Shah AA, K N, Lobo R. Mechanistic targets for BPH and prostate cancer-a review. Reviews on Environmental Health. 2021 Jun; 36(2): 261-70. doi: 10.1515/reveh-2020-0051.

Phua TJ. The etiology and pathophysiology genesis of benign prostatic hyperplasia and prostate cancer: a new perspective. Medicines. 2021 Jun; 8(6): 30. doi: 10.3390/medicines8060030.

Xiong Y, Zhang Y, Li X, Qin F, Yuan J. The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males. The Aging Male. 2020 Dec; 23(5): 1432-9. doi: 10.1080/13685538.2020.1781806.

Malik MA, Khan JH, Gondal WS, Bajwa IA. Role of uroflowmetry in lower urinary tract symptoms evaluation due to benign prostatic hyperplasia (BPH). Annals of King Edward Medical University. 2010; 16(1). doi: 10.21649/akemu.v16i1%20SI.153.

Macey MR, Raynor MC. Diagnosis of benign prostatic hyperplasia. Prostatic Artery Embolization. 2020: 11-9. doi: 10.1007/978-3-030-23471-3_2.

Kaplan SA, Kohler TS, Kausik SJ. Noninvasive pressure flow studies in the evaluation of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of 50,000 patients. The Journal of Urology. 2020 Dec; 204(6): 1296-304. doi: 10.1097/JU.0000000000001195.

Oranusi CK, Nwofor AE, Mbonu O. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia. Nigerian Journal of clinical practice. 2017 May; 20(4): 454-8. doi: 10.4103/1119-3077.196120.

Singla S, Garg R, Singla A, Sharma S, Singh J, Sethi P. Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia. Journal of clinical and diagnostic research. 2014 Apr; 8(4): NC01. doi: 10.7860/JCDR/2014/7909.4271.

Gan ZS and Smith AL. Questionnaires to Evaluate Lower Urinary Tract Symptoms in Men and Women. Current Bladder Dysfunction Reports. 2021 Sep; 16(3): 80-6. doi: 10.1007/s11884-021-00633-4.

Victor A and Okigbeye D. Benign Prostatic Enlargement, the International Prostate Symptoms Score and a Review of Other Symptom Scores. Open Journal of Urology. 2022 Aug; 12(8): 427-39. doi: 10.4236/oju.2022.128042.

Yao MW, Green JS. How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self‐administered patient questionnaire for male lower urinary tract symptoms. LUTS: Lower Urinary Tract Symptoms. 2022 Mar; 14(2): 92-101. doi: 10.1111/luts.12415.

Sullivan L. Power and sample size determination. 2020. doi: 10.1111/luts.12415.

Majed AA, Khalid GA, Humadi AF, Al-Talabi A, Al-Bayaty A. Advancements in uroflowmetry: A comprehensive review of non-invasive urodynamic assessment and developmental prototypes for home monitoring. InAIP Conference Proceedings; AIP Publishing. 2024. doi:10.1063/5.0237140.

Mostafa D, Higazy A, Ali MH, Elsayaad MF, Abuelnaga M. Evaluation of a noninvasive uroflowmetry parameter (Delta Q value) in detrusor underactivity and bladder outlet obstruction. The Egyptian Journal of Surgery. 2023 Jul; 42(3): 647-51. doi: 10.4103/ejs.ejs_126_23.

Mevcha A and Napier‐Hemy R. Uroflowmetry. Abrams' Urodynamics. 2021 May: 93-108. doi: 10.1002/9781119245957.ch6.

Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I, initial work-up and medical management. The Journal of urology. 2021 Oct; 206(4): 806-17. doi: 10.1097/JU.0000000000002183.

Almas F, Dasdelen MF, Seyhan Z, Sargolzaeimoghaddam M, Sarg A, Unlu O et al. Reassessing Normal Voiding Standards: A Cross-Sectional Study Based on Medical Professionals' Evaluations with Portable Uroflowmetry and IPSS. Journal of Clinical Medicine. 2024 May; 13(10): 2857. doi: 10.3390/jcm13102857.

Baboudjian M, Hashim H, Bhatt N, Creta M, De Nunzio C, Gacci M, Herrmann T, Karavitakis M, Malde S, Moris L, Netsch C. Summary paper on underactive bladder from the European Association of Urology guidelines on non-neurogenic male lower urinary tract symptoms. European Urology. 2024 Apr. doi: 10.1016/j.eururo.2024.04.004.

Franco JV, Jung JH, Imamura M, Borofsky M, Omar MI, Liquitay CM et al. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis. Cochrane Database of Systematic Reviews. 2021 Jul; 7(7): CD013656. doi: 10.1002/14651858.CD013656.pub2.

Alrabadi A, Al Demour S, Mansi H, AlHamss S, Al Omari L. Evaluation of voiding position on uroflowmetry parameters and post-void residual urine in patients with benign prostatic hyperplasia and healthy men. American Journal of Mens Health. 2020 Jul-Aug; 14(4): 1557988320938969. doi: 10.1177/1557988320938969.

Haritha V, Rao SD, Rahman SS. Microbiological Profile of Urinary Tract Infections in Males: A Cross-sectional Study. Journal of Clinical and Diagnostic Research. 2023 Mar; 17(3): 11-6. doi: 10.7860/JCDR/2023/62386.17635.